|

Implementation of Precision Medicine in High-risk Prostate Cancer

RECRUITINGSponsored by Andreas Josefsson
Actively Recruiting
SponsorAndreas Josefsson
Started2024-06-10
Est. completion2054-12
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06687421

Summary

This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Men investigated for suspected prostate cancer
* Signed consent form

Exclusion Criteria:

* Difficulties understanding information about the study due to linguistic, cognitive or other reason

Conditions2

CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.